Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) to Indivior Pharmaceuticals, Inc. for 1.5401 common shares of Indivior for each share of Supernus.Halper Sadeh encourages Supernus shareholders to click here to learn more about...
Business Wire
More News
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
Investors need to pay close attention to SUPN stock based on the movements in the options market lately.
Zacks
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
INDV's proposed Supernus merger could broaden its CNS portfolio, cut costs and reduce reliance on Sublocade, but closing remains uncertain.
Zacks
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Indivior's Sublocade growth and cost cuts are lifting earnings and cash flow, but pipeline setbacks, legal risks and valuation add caution.
Zacks
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
BIIB's newer drugs, M&A activity and pipeline progress are fueling its turnaround, but declining MS sales remain a key risk.
Zacks
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 7, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
SUPN vs. TEVA: Which Stock Is the Better Value Option?
Zacks
New Strong Buy Stocks for August 7th
EDRY, OPBK, SUPN, MSBI and NXRT have been added to the Zacks Rank #1 (Strong Buy) List on August 7th, 2026.
Zacks
Best Value Stocks to Buy for August 7th
BCAL, SUPN and NXRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 7th, 2026.
Zacks
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings and revenue estimates and raises its 2026 outlook.
Zacks

Advertisement|Remove ads.